Developer of a breath-based diagnostic platform designed for early lung cancer detection. The company's technology utilizes a proprietary collection device and laboratory process to analyze molecular signals from exhaled breath, enabling clinicians to get a non-invasive alternative to imaging and tissue biopsies to identify respiratory diseases in primary care settings.